US1167941087
US1167941087
Bruker Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 8.96B EUR | 9.17B EUR | 5.5B EUR | 7.17B EUR |
Enterprise Value | 10.55B EUR | 10.81B EUR | 7.04B EUR | 8.91B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 24.59x | -- | -- | -- |
Price to Sales | 2.56x | 2.62x | 1.59x | 2.72x |
Price to Book | 3.76x | 3.85x | 2.25x | 2.92x |
EV/Revenue | 3.01x | 3.09x | 2.03x | 3.38x |
EV/EBITDA | 19.5x | 20.02x | 16.02x | 26.4x |
Price to FCF (P/FCF) | 49.82x | 142.15x | 251.06x | -- |
EV/FCF | 58.63x | 167.57x | 321.29x | -- |
FCF Yield | 2.01% | 0.7% | 0.4% | -0.35% |